Clinical Trials · NCT02005887
TRial on the Endocrine Activity of Neoadjuvant Degarelix
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Enrollment
- 51
- Start date
- Feb 2014
- Locations
- 7 sites, Italy
- Primary endpoint
- Time to Optimal Ovarian Function Suppression